#Pharmaceutical manufacturer AstraZeneca has accepted for the first time that its COVID-19 vaccine can, “in very rare cases,” cause thrombosis with thrombocytopenia syndrome (TTS), which is characterised by blood clots (#thrombosis) and low red blood cell counts (#thrombocytopenia). It is also called vaccine-induced immune #thrombotic thrombocytopenia (VITT).
#covid19 #astrazeneca #covid19vaccine
